SINYSESurgical & Medical Instruments & ApparatusUS GAAP · USD

Shoulder Innovations, Inc

Shoulder Innovations, Inc. is a U.S.-based commercial-stage medical technology company focused exclusively on shoulder surgical care. It develops and sells implant systems for shoulder arthroplasty, along with supporting technologies, instruments, and surgeon education tools used in hospital and outpatient settings.

Kysy yhtiöstä
Liikevaihto47,3milj. USD
+49,6 %v/v
Liikevoitto (EBIT)−26,3milj. USD
−79,5 %v/v
EBIT-marginaali−55,6%
−9,2 %-yks.v/v
Nettotulos−40,4milj. USD
−158,4 %v/v
Vapaa kassavirta−36,0milj. USD
−98,4 %v/v

Tilikausi 2025 · muutos edellisvuodesta

Kehitys 2024–2025

−40−200204060milj. USD2024: 32 milj. USD2024: EBIT −15 milj. USD20242025: 47 milj. USD2025: EBIT −26 milj. USD202547−26
LiikevaihtoLiikevoitto (EBIT)
Kysy Clarifolta: Shoulder Innovations, Inc

Liiketoiminta

Osuus liikevaihdosta
Shoulder arthroplasty implants80 %

Primary implant systems for anatomic and reverse shoulder replacement procedures.

Implant components15 %

Core implant parts such as the InSet Glenoid and humeral stem products.

Enabling technologies and planning tools3 %

Digital and workflow tools that support surgical planning and execution.

Instruments and procedural support2 %

Specialized instrument systems, case coverage, and clinical support services.

Asiakkaat

The company sells primarily to hospitals, outpatient centers, and ambulatory surgery centers that perform shoulder arthroplasty procedures. Its commercial model also depends on shoulder specialists and high-volume surgeons, who influence product selection and adoption through clinical preference and training.

Hospitals

Buy shoulder arthroplasty implant systems for inpatient and complex procedures; important for procedure volume and surgeon access.

Outpatient centers

Buy systems optimized for efficient shoulder replacement workflows and shorter stays.

Ambulatory surgery centers (ASCs)

Buy shoulder systems that fit constrained operating rooms and support outpatient care.

Shoulder specialists and surgeons

Influence product adoption by selecting the implant platform and training on its use.

Strategia

The company’s strategy is to deepen its focus on shoulder surgery by expanding its implant ecosystem, surgeon support, and digital workflow tools. It is also building adjacent products such as revision, fracture-specific, and robotics-enabled solutions to broaden its addressable market and strengthen surgeon adoption.

Broaden the product pipeline in shoulder arthroplastyKeskipitkä aikaväli

More indications and implant options can increase procedure coverage and customer retention.

Advance shoulder-specific robotics and digital enablementKeskipitkä aikaväli

Workflow and precision tools can differentiate the platform and support surgeon adoption.

Deepen surgeon relationships and commercial reachLyhyt aikaväli

Adoption depends on education, support, and repeat use by shoulder specialists.

Expand into adjacent shoulder-care marketsPitkä aikaväli

Sports medicine and trauma could extend the company beyond arthroplasty.

Maantiede

The business currently derives revenue from the United States, where it sells through a dedicated commercial team and independent distributors. Management also describes international shoulder surgery markets as a longer-term opportunity, but the disclosed commercial footprint is U.S.-centric.

Riskit

The business depends on surgeon acceptance, training, and proof that its systems outperform established competitors, so adoption risk is central. It also faces product-liability, intellectual-property, reimbursement, and commercialization risks typical of medical device companies, with added exposure to new-product launch risk and distributor execution.

Järjestetty vakavuuden mukaan
MatalaKohtalainenKorkeaMatalaKohtalainenKorkeaVaikutus →Todennäköisyys →Surgeon adoption and market acceptance risk1Competitive pressure from larger orthopedic device companies2Product liability and quality risk3Intellectual property litigation or license risk4Reimbursement and pricing pressure5
Vaikutus on riskin vakavuus ja todennäköisyys sen toteutumisen todennäköisyys lähivuosina, molemmat arvioitu yhtiön raporttien perusteella. Numerot vastaavat listaa.
  1. Surgeon adoption and market acceptance riskVaikutus: KorkeaTodennäköisyys: Kohtalainen

    Surgeons choose the implant platform, so weak clinical acceptance can limit sales growth.

    Kohdistuu: Core implant systems and new product launches

  2. Competitive pressure from larger orthopedic device companiesVaikutus: KorkeaTodennäköisyys: Kohtalainen

    Competitors have broader scale, longer histories, and entrenched relationships.

    Kohdistuu: U.S. shoulder arthroplasty market

  3. Product liability and quality riskVaikutus: KorkeaTodennäköisyys: Kohtalainen

    Implant performance or adverse outcomes can trigger claims and harm reputation.

    Kohdistuu: Implant systems and surgical technologies

  4. Intellectual property litigation or license riskVaikutus: KeskitasoTodennäköisyys: Kohtalainen

    IP disputes can block products, raise costs, or distract management.

    Kohdistuu: Proprietary implant and technology portfolio

  5. Reimbursement and pricing pressureVaikutus: KeskitasoTodennäköisyys: Kohtalainen

    Lower coverage or pricing pressure can slow adoption and compress economics for customers.

    KohdistuuHospitalOutpatientASC procedures
Kysy Clarifolta: Shoulder Innovations, Inc

Kirjanpito

Harkinnanvaraiset erät
Revenue recognition timing

Revenue depends on when control transfers, which is tied to procedure use rather than shipment alone.

Vaikutus: Can shift revenue between quarters based on case timing

Sales tax and shipping presentation

Revenue is reported net of expected sales taxes and includes shipping/handling as revenue.

Vaikutus: Affects gross revenue presentation and comparability

Quarterly variability

Procedure volumes and distributor execution can create uneven period-to-period results.

Vaikutus: Can make quarterly trends noisy

Samankaltaisia listattuja yhtiöitä

Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.

SS Innovations International, Inc.

SSII · Surgical & Medical Instruments & Apparatus

Tenon Medical, Inc.

TNONW · Surgical & Medical Instruments & Apparatus

Integra LifeSciences Holdings Corporation

IART · Surgical & Medical Instruments & Apparatus

Enovis CORP

ENOV · Orthopedic, Prosthetic & Surgical Appliances & Supplies

Sanara MedTech Inc.

SMTI · Orthopedic, Prosthetic & Surgical Appliances & Supplies

Stryker Corporation

SYK · Surgical & Medical Instruments & Apparatus

Päivitetty: 24.9.2026

Shoulder Innovations, Inc (NYSE) – Surgical & Medical Instruments & Apparat | Analyysi – Clarifo